Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 69 Total
BHVN - Biohaven Ltd - Stock Price Chart
TickerBHVN [NYSE, RUT]
CompanyBiohaven Ltd
CountryUSA
IndustryBiotechnology
Market Cap1.37BEPS (ttm)-9.37
P/E-EPS this Y16.89%
Forward P/E-EPS next Y17.59%
PEG-EPS past 5Y-49.78%
P/S-EPS next 5Y18.05%
P/B5.28EPS Q/Q1.15%
Dividend-Sales Q/Q-
Insider Own12.68%Inst Own88.83%
Insider Trans0.25%Inst Trans-1.67%
Short Float13.73%EarningsMay 12/a
Analyst Recom1.25Target Price54.21
Avg Volume2.16M52W Range13.69 - 55.70
Today 08:59AM Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform (Insider Monkey) -5.36%
Jun-10-25 02:00PM Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development (GlobeNewswire)
May-29-25 07:01AM Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor (PR Newswire)
12:16AM Biohaven Ltd. (BHVN)'s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy (Insider Monkey)
May-28-25 03:00PM Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN) (PR Newswire)
07:30AM Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors (PR Newswire)
May-15-25 06:03PM Why Biohaven Stock Dove by Nearly 20% on Thursday (Motley Fool) -19.53%
02:06PM Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug (Investor's Business Daily)
01:22PM Why Is Biohaven Stock Falling On Thursday? (Benzinga)
May-14-25 06:43PM FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia (PR Newswire)
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHILDS JOHN WDirectorMar 04 '25Buy30.4732,700996,2382,320,571Mar 05 07:01 AM
Car BruceChief Scientific OfficerJan 05 '25Option Exercise0.004,75007,133Jan 07 08:51 PM
Gentile KimberlySVP, Clinical OperationsJan 05 '25Option Exercise0.003,750099,719Jan 07 08:50 PM
Clark George C.VP, Chief Accounting OfficerJan 05 '25Option Exercise0.002,500066,168Jan 07 08:50 PM
Buten MatthewChief Financial OfficerJan 05 '25Option Exercise0.004,2500196,013Jan 07 08:49 PM
HELE - Helen of Troy Ltd - Stock Price Chart
TickerHELE [NASD, RUT]
CompanyHelen of Troy Ltd
CountryBermuda
IndustryHousehold & Personal Products
Market Cap477.24MEPS (ttm)-14.51
P/E-EPS this Y-36.92%
Forward P/E4.17EPS next Y10.25%
PEG-EPS past 5Y-2.26%
P/S0.26EPS next 5Y-
P/B0.39EPS Q/Q-7583.85%
Dividend-Sales Q/Q-10.63%
Insider Own1.99%Inst Own105.11%
Insider Trans0.00%Inst Trans0.33%
Short Float13.24%EarningsJul 10/b
Analyst Recom2.33Target Price38.33
Avg Volume865.92K52W Range21.07 - 77.95
Helen of Troy Ltd. operates as a global consumer products company offering creative products and solutions for its customers. It offers its services through brands including OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon, and Olive & June. The firm operates through the Home and Outdoor, and Beauty and Wellness segments. The Home and Outdoor segment offers food preparation tools, containers, electronics, baby care, and cleaning products. The Beauty and Wellness segment develops and provides products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans. The company was founded by Gerald J. Rubin and Stanlee N. Rubin in 1968 and is headquartered in Hamilton, Bermuda.
WEAV - Weave Communications Inc - Stock Price Chart
TickerWEAV [NYSE, RUT]
CompanyWeave Communications Inc
CountryUSA
IndustryHealth Information Services
Market Cap559.35MEPS (ttm)-0.41
P/E-EPS this Y9.23%
Forward P/E52.66EPS next Y158.68%
PEG-EPS past 5Y5.67%
P/S2.63EPS next 5Y84.01%
P/B8.13EPS Q/Q-17.03%
Dividend-Sales Q/Q18.31%
Insider Own14.45%Inst Own81.32%
Insider Trans-9.47%Inst Trans9.16%
Short Float4.65%EarningsMay 05/a
Analyst Recom1.57Target Price14.14
Avg Volume839.19K52W Range7.53 - 17.63
Weave Communications, Inc. develops a customer communication platform for service-based businesses. It offers voice, short message service, email and marketing services to dental, optometry, medical, and veterinary offices. The company was founded by Clint Berry, Brandon Rodman, and Jared Rodman in September 2008 and is headquartered in Lehi, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Christiansen Jason PaulChief Financial OfficerJun 16 '25Sale8.594,07034,961324,938Jun 20 04:14 PM
Christiansen Jason PaulChief Financial OfficerJun 17 '25Sale8.483,94033,411320,998Jun 20 04:14 PM
Christiansen Jason PaulOfficerJun 20 '25Proposed Sale8.483,94033,411Jun 20 11:13 AM
Christiansen Jason PaulOfficerJun 20 '25Proposed Sale8.594,07034,943Jun 20 10:59 AM
Bertilson MarcusChief Operating OfficerJun 17 '25Sale8.5311,40997,319352,093Jun 18 04:25 PM
TNDM - Tandem Diabetes Care Inc - Stock Price Chart
TickerTNDM [NASD, RUT]
CompanyTandem Diabetes Care Inc
CountryUSA
IndustryMedical Devices
Market Cap1.01BEPS (ttm)-2.78
P/E-EPS this Y6.17%
Forward P/E-EPS next Y53.24%
PEG-EPS past 5Y-28.23%
P/S1.03EPS next 5Y71.44%
P/B6.51EPS Q/Q-200.67%
Dividend-Sales Q/Q22.30%
Insider Own0.96%Inst Own110.51%
Insider Trans1.68%Inst Trans1.56%
Short Float14.78%EarningsAug 06/a
Analyst Recom2.28Target Price34.10
Avg Volume1.58M52W Range15.17 - 48.24
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carpenter RickChief Technology OfficerJun 16 '25Option Exercise0.00406021,426Jun 18 04:08 PM
Novara Mark DavidEVP & CHIEF COMMERCIAL OFFICERJun 16 '25Option Exercise0.007,414032,609Jun 18 04:08 PM
Cha MyoungilDirectorJun 16 '25Option Exercise0.001,749013,699Jun 18 04:08 PM
Malagueira Joao Paulo FalcaoDirectorJun 16 '25Option Exercise0.001,749013,699Jun 18 04:07 PM
Sodhi RajwantDirectorMay 22 '25Option Exercise20.644,38790,54815,521May 23 04:04 PM
PCG - PG&E Corp - Stock Price Chart
TickerPCG [NYSE, S&P 500]
CompanyPG&E Corp
CountryUSA
IndustryUtilities - Regulated Electric
Market Cap28.64BEPS (ttm)1.09
P/E11.98EPS this Y10.36%
Forward P/E7.99EPS next Y8.65%
PEG1.27EPS past 5Y-
P/S1.17EPS next 5Y9.42%
P/B0.98EPS Q/Q-19.37%
Dividend0.73%Sales Q/Q2.08%
Insider Own0.54%Inst Own95.49%
Insider Trans-1.87%Inst Trans0.94%
Short Float1.46%EarningsJul 31/b
Analyst Recom1.94Target Price20.85
Avg Volume22.79M52W Range13.20 - 21.72
PG&E Corp. operates as a holding company, which engages in generation, transmission, and distribution of electricity and natural gas to customers. It specializes in energy, utility, power, gas, electricity, solar and sustainability. The company was founded in 1995 and is headquartered in Oakland, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Peterman Carla JEVP/Corp. Affairs & CSOApr 29 '25Sale17.3032,519562,579151,116May 01 04:33 PM
Peterman Carla JOfficerApr 29 '25Proposed Sale17.3032,519562,497Apr 29 04:35 PM
DENAULT LEO PDirectorMar 11 '25Buy15.966,300100,5486,300Mar 12 04:27 PM
Glickman Jason MEVP, EPS at PG&E CompanyMar 10 '25Sale15.7140,239632,155148,124Mar 11 04:36 PM
Glickman Jason MOfficerMar 10 '25Proposed Sale15.7140,239631,954Mar 10 05:12 PM
AVNS - Avanos Medical Inc - Stock Price Chart
TickerAVNS [NYSE, RUT]
CompanyAvanos Medical Inc
CountryUSA
IndustryMedical Devices
Market Cap535.50MEPS (ttm)-8.36
P/E-EPS this Y-37.04%
Forward P/E10.53EPS next Y29.41%
PEG-EPS past 5Y-54.63%
P/S0.78EPS next 5Y-
P/B0.64EPS Q/Q823.08%
Dividend-Sales Q/Q0.84%
Insider Own3.21%Inst Own94.50%
Insider Trans-0.47%Inst Trans1.06%
Short Float3.26%EarningsMay 06/b
Analyst Recom3.00Target Price14.00
Avg Volume459.56K52W Range11.68 - 25.36
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holbrook KerrSVP, Chief Commercial OfficerMar 06 '25Sale15.257,000106,77882,047Mar 10 11:50 AM
Holbrook KerrOfficerMar 06 '25Proposed Sale15.257,000106,780Mar 06 05:05 PM
James MojiradeSVP, General CounselMar 04 '25Option Exercise0.008,039078,352Mar 06 02:25 PM
Woody Joseph FralinFormer Chief Executive OfficerMar 04 '25Option Exercise0.0032,1580453,203Mar 06 02:25 PM
Holbrook KerrSVP, Chief Commercial OfficerMar 04 '25Option Exercise0.005,145092,393Mar 06 02:24 PM
MSPR - MSP Recovery Inc - Stock Price Chart
TickerMSPR [NASD]
CompanyMSP Recovery Inc
CountryUSA
IndustryHealth Information Services
Market Cap7.95MEPS (ttm)-233.42
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-69.28%
P/S0.61EPS next 5Y-
P/B-EPS Q/Q-7.19%
Dividend-Sales Q/Q-86.05%
Insider Own34.38%Inst Own8.82%
Insider Trans0.00%Inst Trans367.32%
Short Float5.93%Earnings-
Analyst Recom1.00Target Price1875.00
Avg Volume279.58K52W Range0.91 - 13.50
Today 07:17AM Maryland Supreme Court Affirms MSP Recovery's Assignments, Paving the Way for Class Action Lawsuit Against GEICO (GlobeNewswire)
Apr-16-25 06:06AM MSP Recovery Announces Fiscal Year and Fourth Quarter 2024 Financial Results (GlobeNewswire) -24.24%
Apr-10-25 07:26PM MSP Recovery Announces Strategic Term Sheet Providing Prospective Liquidity and Restructuring of Existing Agreements to Remove Corporate Guaranteed Debt by over $1.2 Billion as Well as New Agreements Aimed at Driving Future Growth (GlobeNewswire) -7.25% +95.31%
Dec-06-24 12:52AM LifeWallet Announces Consolidation of All Lines of Business Under the MSP Recovery Brand, While Advancing Initiatives That Align With the Newly Formed Department of Government Efficiency (DOGE) (GlobeNewswire) +103.77%
Nov-21-24 11:43PM LifeWallet Announces a $2 Million Pharmaceutical Litigation Settlement and Ongoing Settlement Negotiations with Multiple PandC Insurers, Pharmaceutical and Medical Device Manufacturers, While Advancing Efforts to Combat Systemic Medicare Waste, Which Aligns With Initiatives of the Newly-Formed Department of Government Efficiency (DOGE) (GlobeNewswire) -8.07% +29.73%
11:43PM LifeWallet Announces a $2 Million Pharmaceutical Litigation Settlement and Ongoing Settlement Negotiations with Multiple P&C Insurers, Pharmaceutical and Medical Device Manufacturers, While Advancing Efforts to Combat Systemic Medicare Waste, Which Aligns With Initiatives of the Newly-Formed Department of Government Efficiency (DOGE) (GlobeNewswire)
Nov-14-24 04:24PM LifeWallet Announces Third Quarter 2024 Financial Results (GlobeNewswire) -5.93% -20.87%
Nov-12-24 12:00PM LifeWallet Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement (GlobeNewswire) -10.10%
Nov-11-24 10:21PM LifeWallet Announces New Comprehensive Settlements Totaling More Than $5.9 Million, Continued Progress in Recoveries on Owned Claims and Acquiring Rights to Additional Claims, and Initiatives to Eliminate Wasteful Medicare Spending by Launching Beta Testing of Its Clearinghouse Solution, Built in Partnership with Palantir Technologies, Inc. (GlobeNewswire)
Oct-02-24 09:22AM LifeWallet Acquires Assignment of Additional MSP Claims with an Overall Paid Amount Exceeding $10.6 billion Comprised of Over 450,000 Medicare Members and Announces it Secured a Waiver of Acceleration on a Second Loan Agreement in the Event of a Negative Going Concern (GlobeNewswire) +14.37%
MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Palantir Technologies Inc.Former 10% OwnerNov 06 '24Sale0.13506,29665,7172,985,381Nov 06 08:32 PM
Palantir Technologies Inc.Former 10% OwnerNov 05 '24Sale0.11340,30037,3313,491,677Nov 06 08:32 PM
Palantir Technologies Inc.Former 10% OwnerNov 04 '24Sale0.10111,76011,2993,831,977Nov 06 08:32 PM
Palantir Technologies Inc.10% OwnerOct 31 '24Sale0.11381,48742,8034,280,911Nov 01 08:03 PM
Palantir Technologies Inc.10% OwnerNov 01 '24Sale0.11337,17435,7743,943,737Nov 01 08:03 PM
WAT - Waters Corp - Stock Price Chart
TickerWAT [NYSE, S&P 500]
CompanyWaters Corp
CountryUSA
IndustryDiagnostics & Research
Market Cap17.46BEPS (ttm)11.03
P/E26.61EPS this Y9.21%
Forward P/E20.57EPS next Y10.11%
PEG2.63EPS past 5Y4.28%
P/S5.85EPS next 5Y10.10%
P/B8.90EPS Q/Q18.21%
Dividend-Sales Q/Q3.90%
Insider Own0.22%Inst Own98.31%
Insider Trans0.00%Inst Trans1.86%
Short Float3.13%EarningsAug 04/b
Analyst Recom2.40Target Price387.64
Avg Volume537.37K52W Range297.14 - 423.56
Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments. The Waters segment consists of liquid chromatography instruments, mass spectrometry, and precision chemistry consumable products and services. The TA segment products and services include thermal analysis, rheometry and calorimetry instrument systems, and service sales. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.
ATEX - Anterix Inc - Stock Price Chart
TickerATEX [NASD, RUT]
CompanyAnterix Inc
CountryUSA
IndustryTelecom Services
Market Cap434.30MEPS (ttm)-0.62
P/E-EPS this Y-34.85%
Forward P/E-EPS next Y-124.95%
PEG-EPS past 5Y23.19%
P/S72.02EPS next 5Y-
P/B2.76EPS Q/Q196.66%
Dividend-Sales Q/Q10.24%
Insider Own3.41%Inst Own88.75%
Insider Trans-5.26%Inst Trans5.30%
Short Float5.26%EarningsJun 24/a
Analyst Recom1.00Target Price70.33
Avg Volume151.06K52W Range23.40 - 42.91
Anterix, Inc. engages in commercializing spectrum assets to enable targeted utility and critical infrastructure customers to deploy private broadband networks, technologies and solutions. Its solutions include Private LTE and Active Ecosystem. The company was founded by Peter Joel Lasensky and Richard Edward Rohmann in 1997 and is headquartered in Woodland Park, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heard WilliamDirectorFeb 14 '25Sale41.187,900325,3221,744,238Apr 17 03:57 PM
Heard WilliamDirectorMar 17 '25Sale38.738,251319,5611,733,738Apr 17 03:57 PM
Heard WilliamDirectorMar 20 '25Sale38.407,000268,8001,720,238Apr 17 03:57 PM
Heard WilliamDirectorMar 19 '25Sale38.936,500253,0451,727,238Apr 17 03:57 PM
Heard WilliamDirectorMar 21 '25Sale37.973,500132,8951,716,738Apr 17 03:57 PM
LEXX - Lexaria Bioscience Corp - Stock Price Chart
TickerLEXX [NASD]
CompanyLexaria Bioscience Corp
CountryCanada
IndustryBiotechnology
Market Cap15.86MEPS (ttm)-0.66
P/E-EPS this Y-27.66%
Forward P/E-EPS next Y21.67%
PEG-EPS past 5Y21.61%
P/S25.58EPS next 5Y6.84%
P/B2.85EPS Q/Q-61.04%
Dividend-Sales Q/Q107.14%
Insider Own7.88%Inst Own6.39%
Insider Trans0.00%Inst Trans-13.92%
Short Float2.88%EarningsApr 15
Analyst Recom1.00Target Price6.50
Avg Volume112.75K52W Range0.82 - 4.38
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. It operates through the following segments: IP Licensing, B2B Product, Research and Development, and Corporate. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHRISTOPHER RICHARDChief Executive OfficerDec 03 '24Buy2.4727,17267,17550,000Dec 03 02:03 PM
CHRISTOPHER RICHARDChief Executive OfficerDec 02 '24Buy2.2422,82851,21722,828Dec 03 02:03 PM
TURKEL CATHERINE C.DirectorAug 12 '24Buy3.131,6005,0083,100Aug 13 10:55 AM
Carle VanessaSecretaryJul 31 '24Sale4.002,56710,2680Aug 01 12:25 PM
1234567